Telehealth General Psychiatry Prescribing: What Psychiatrists Can Do in Georgia

If you’re a psychiatrist or PMHNP trying to figure out whether you can legally prescribe medications through telehealth — especially controlled substances like stimulants or benzos — you’re not alone. The rules are scattered across federal waivers, state laws, and scope-of-practice regulations that seem to change every legislative session.

Here’s the real answer: Yes, psychiatrists can prescribe almost anything via telehealth right now, including Schedule II stimulants for ADHD and benzodiazepines for anxiety. PMHNPs can too — if their state allows it and they meet supervision requirements where applicable. But the details matter, because what’s legal in New York might get you flagged in Texas.

Let’s break down what you actually need to know to prescribe safely and compliantly via telemedicine in 2026.

Federal Rules: The DEA’s Temporary Telehealth Allowance

Normally, federal law (the Ryan Haight Act) requires an in-person medical evaluation before prescribing controlled substances. That rule essentially killed telehealth prescribing for ADHD, anxiety disorders, and opioid use disorder — until COVID-19 changed everything.

Current status (as of February 2026): The DEA extended its emergency telemedicine waiver through December 31, 2025, allowing providers to prescribe controlled substances via telehealth without an initial in-person visit (texasnp.org). That means you can start a new patient on Adderall, Xanax, or buprenorphine after a secure video visit — no in-person exam required.

But here’s the catch: The DEA has been threatening to reimpose in-person requirements for years. Proposed rules have floated ideas like requiring an in-person visit after the first 30-day supply, or mandating special telehealth registrations. Nothing is finalized yet, but psychiatrists should expect some version of tighter rules by late 2026 (www.nixonpeabody.com).

What this means for you: As long as the waiver is in effect, you’re covered federally. But stay alert. Subscribe to DEA updates or your state psychiatric association’s listserv so you’re not caught off-guard when rules change. And document everything — patient identity verification, informed consent for telehealth, clinical rationale for controlled substance prescriptions.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State: Where Psychiatrists Can Prescribe What

Federal law sets the floor, but states can impose additional restrictions. Some states explicitly allow teleprescribing for mental health treatment, while others have carve-outs or outright bans for certain medications.

California

Psychiatrists (MD/DO) in California can prescribe any psychiatric medication via telehealth, including controlled substances, as long as the ‘good faith exam’ standard is met — and a video visit qualifies (natlawreview.com).

What’s different here: California requires checking the CURES database (the state prescription monitoring program) before prescribing Schedule II–IV drugs. That includes stimulants for ADHD and benzos. Miss this step and you’re technically non-compliant, even if the prescription itself was appropriate.

PMHNPs in California: As of 2023, experienced NPs (3+ years) can practice with significant autonomy under the new ‘103 NP’ certification. By January 2026, they’ll be able to achieve full independent practice (104 NP status), meaning they can prescribe just like psychiatrists — no physician supervision required (www.rn.ca.gov). New grad PMHNPs still need physician oversight via standardized procedures for their first few years.

Texas

Texas law allows telemedicine prescribing if the standard of care is met and the encounter is conducted via real-time audio-video interaction (www.cchpca.org). Psychiatrists can prescribe controlled substances for mental health conditions via telehealth — that includes stimulants for ADHD and benzos for anxiety.

The big exception: Texas prohibits prescribing Schedule II opioids for chronic pain via telemedicine. If you’re managing long-term pain, you need an in-person exam. But for psychiatric treatment? You’re clear.

PMHNPs in Texas: This is where it gets restrictive. Texas does not allow NP independent practice. Every PMHNP must have a written Prescriptive Authority Agreement with a Texas-licensed physician to prescribe anything — even over-the-counter meds technically fall under this (www.bon.texas.gov).

And here’s the kicker: Texas NPs generally cannot prescribe Schedule II controlled substances in outpatient settings, except in very narrow circumstances (terminal illness, emergency care) (www.cchpca.org). That means a PMHNP in Texas typically can’t write a script for Adderall or Ritalin — the supervising psychiatrist needs to handle those prescriptions.

Texas also caps one physician to supervising seven NPs or PAs at a time, and requires monthly face-to-face meetings for the first three years of collaboration (capitol.texas.gov). If you’re a psychiatrist supervising NPs on a telehealth platform, that’s administrative overhead you need to budget for.

Practical reality: Most telepsychiatry companies operating in Texas have psychiatrists handle ADHD cases and reserve NPs for non-controlled medication management (SSRIs, mood stabilizers, etc.). It’s clunky, but it’s compliant.

Florida

Florida is surprisingly permissive on telehealth prescribing. State law explicitly allows controlled substances to be prescribed via telehealth for the treatment of psychiatric disorders (www.flsenate.gov). That’s a statutory carve-out — Florida otherwise restricts telemedicine prescribing of controlled substances for chronic pain, but mental health got an exception.

For psychiatrists: You can initiate and manage ADHD stimulants, anxiety meds, and other controlled substances entirely via video visits for Florida patients. Just ensure your evaluation is thorough and documented.

PMHNPs in Florida: Florida’s 2020 law (HB 607) allows some NPs to practice autonomously, but psychiatric NPs were excluded from that independence (www.npschools.com). PMHNPs still need a supervising physician protocol.

However, Florida defines a ‘psychiatric nurse’ as a PMHNP with 2+ years of experience under a psychiatrist, and those psychiatric nurses can prescribe psychotropic controlled substances without the 7-day Schedule II limit that applies to other NPs (www.flsenate.gov). Translation: an experienced PMHNP in Florida can write a 30-day Adderall script for a patient with ADHD, but they need a collaborating psychiatrist on paper.

New York

New York updated its regulations in 2023 to align with federal DEA flexibilities. The state now permits telemedicine prescribing of controlled substances when consistent with federal law (www.nixonpeabody.com). That means psychiatrists can prescribe via telehealth under the current DEA waiver without fear of state-level violations.

PMHNPs in New York: New York has one of the more progressive NP laws. After completing 3,600 hours of practice (about two years full-time) under a written collaborative agreement, PMHNPs can practice independently — no ongoing supervision or chart co-signing required (www.jdsupra.com). They’re required to maintain a ‘collaborative relationship’ (informal consultation arrangement), but there’s no physician oversight of prescribing.

So an experienced PMHNP in New York can prescribe controlled substances via telehealth just like a psychiatrist. New grads need supervision initially, but the path to independence is clear.

Pennsylvania

Pennsylvania requires NPs to have a collaborative agreement with a physician for the entirety of their career — there’s no pathway to independence yet (www.pacnp.org).

For PMHNPs: You can prescribe controlled substances (including Schedule II) if your collaborating physician delegates that authority in the agreement. But Schedule II prescriptions are limited to a 30-day supply, and you must notify the collaborating physician within 24 hours of writing the script.

For psychiatrists: Full prescribing authority, no restrictions beyond standard of care and checking the state’s prescription monitoring program. Telehealth prescribing follows federal rules.

Illinois

Illinois has a transition-to-independence model. PMHNPs must complete 4,000 hours of practice under a written collaborative agreement plus 250 hours of continuing education before they can apply for Full Practice Authority (www.nursepractitionerlicense.com).

Once FPA is granted, Illinois PMHNPs can prescribe independently, including controlled substances. Until then, their prescriptions are technically under physician delegation, and the collaborating physician’s name must appear on scripts.

For psychiatrists: Independent prescribing, telehealth-friendly. Illinois passed payment parity laws for telehealth through 2027, so insurers must reimburse telehealth visits at the same rate as in-person for behavioral health (texasnp.org).

What About Buprenorphine (Suboxone) for Opioid Use Disorder?

Buprenorphine prescribing used to require a special DEA X-waiver. That requirement was eliminated in December 2022 — now any DEA-registered provider can prescribe buprenorphine without additional certification (texasnp.org).

Via telehealth: Under the current federal waiver, psychiatrists and PMHNPs (in states where they have prescriptive authority) can initiate buprenorphine treatment via telehealth without an in-person visit. This has been a game-changer for opioid use disorder treatment access.

State nuances: Some states impose additional training requirements or limits on buprenorphine prescribing. For example, some states cap the number of patients you can treat with buprenorphine unless you have specialized addiction training. Check your state’s medical or nursing board rules.

Reimbursement: Does Telehealth Pay the Same?

For psychiatrists worried about revenue: telehealth pays the same as in-person for most insurers in 2026, thanks to parity laws and Medicare policy.

Medicare rates for 2026 (national average):

• Initial psychiatric evaluation (90792): ~$173 (therathink.com)
• 15-minute med check (99213): ~$95 (therathink.com)
• 25-minute med check (99214): ~$136 (therathink.com)

PMHNPs: Medicare reimburses nurse practitioners at 85% of the physician fee schedule when billed under the NP’s NPI (www.nursepractitioneronline.com). Many private insurers follow similar policies, though some states (Nevada, Maryland) have passed equal reimbursement laws.

Private insurance: Commercial payers often pay more than Medicare, especially in high cost-of-living areas. Many major insurers now cover telehealth at parity for mental health services, meaning they can’t reduce payment solely because the visit was conducted via video.

Key states with telehealth parity laws:

• California: AB 744 (2019) requires payment parity for telehealth
• Illinois: Payment parity through 2027 for behavioral health
• New York: Broad telehealth coverage with reimbursement parity for mental health
• Texas: Covers telehealth but doesn’t mandate payment parity (most insurers voluntarily pay equal rates for mental health)

The Real Compliance Risk: Documentation

Most compliance issues in telepsychiatry aren’t about what you prescribe — they’re about how you document it.

Best practices:

• Verify patient identity and location at the start of every visit. Document the state where the patient is located (you must be licensed there).
• Obtain informed consent for telehealth services, including discussion of limitations (e.g., ‘If you have a psychiatric emergency, call 911 or go to the nearest ER — I can’t physically come to you’).
• Check the prescription monitoring program before prescribing controlled substances. Every state requires this now, usually within 24 hours of prescribing.
• Document the clinical rationale for controlled substance prescriptions, especially for Schedule II meds. ‘Patient meets DSM-5 criteria for ADHD, discussed risks/benefits of stimulant therapy, patient agrees to monthly follow-up’ — that kind of detail.
• Use secure, HIPAA-compliant platforms with end-to-end encryption for video visits. FaceTime and Zoom’s free tier don’t cut it.

If you’re practicing through a platform like Klarity Health, many of these compliance steps are built into the workflow — patient verification, consent forms, automated PMP checks, documentation templates. That’s one less thing to worry about.

The Bottom Line for Providers

If you’re a psychiatrist (MD/DO): You can prescribe almost any psychiatric medication via telehealth in 2026, including controlled substances, as long as you comply with federal DEA waivers and state-specific rules (like checking prescription monitoring programs). The biggest risk is getting caught off-guard when federal rules tighten — stay informed and document thoroughly.

If you’re a PMHNP: Your prescribing authority via telehealth depends entirely on your state’s scope-of-practice laws. In full practice states (or after meeting transition requirements in states like New York and Illinois), you have nearly the same authority as psychiatrists. In restricted states like Texas and Florida, you’ll need physician collaboration — and in Texas, you likely can’t prescribe Schedule II stimulants at all.

What about patient acquisition costs? Many providers assume they can acquire telehealth patients cheaply through DIY marketing. Reality check: acquiring a qualified psychiatric patient through SEO, Google Ads, or directory listings typically costs $200–500+ per patient when you factor in all costs — agency fees, ad spend, lead qualification time, and no-shows. SEO takes 6–12 months of consistent investment before generating meaningful results. Google Ads for mental health keywords run $15–40+ per click, and most clicks don’t convert to booked patients.

Platforms like Klarity Health flip this model: instead of gambling thousands per month on marketing with uncertain results, you pay a standard listing fee per new patient lead — only when a qualified patient actually books with you. No upfront marketing spend, no monthly subscriptions, no wasted ad budget. The platform handles patient acquisition, matching, and telehealth infrastructure. For most providers, especially those starting out or scaling, that’s guaranteed ROI versus months of marketing trial-and-error.

Frequently Asked Questions

Can I prescribe Adderall or Ritalin to a new patient via telehealth in 2026?
Yes, if you’re licensed in the patient’s state and operating under the current DEA emergency waiver (extended through December 31, 2025). Federal law currently allows initial controlled substance prescriptions via telehealth without an in-person visit for mental health treatment (texasnp.org). State-specific rules apply — for example, Texas restricts PMHNP prescribing of Schedule II drugs.

Do I need to see patients in person at all for telehealth prescribing?
Not currently, under federal waivers for mental health. However, proposed DEA rules may require periodic in-person visits in the future (e.g., once every 6–12 months). Some Medicare rules require an in-person visit annually for tele-mental health services, but enforcement has been paused. Stay updated on policy changes.

What if my PMHNP license doesn’t allow independent practice in my state?
You’ll need a collaborative agreement with a physician (often a psychiatrist for psychiatric prescribing). That agreement must outline your scope of practice, prescriptive authority, and supervision/review requirements. Some telehealth platforms provide collaborating physicians as part of their onboarding. In states like Texas, you’ll also face limitations on prescribing Schedule II controlled substances.

Are there differences in what I can prescribe via audio-only (phone) versus video?
Most states and Medicare now allow audio-only telehealth for mental health services, including medication management, as long as the patient cannot access video (aapp.org). However, initial evaluations — especially those involving controlled substance prescriptions — typically require video to meet the ‘standard of care’ assessment. Follow-up med checks can often be done by phone.

Do I have to check the state prescription monitoring program every time I prescribe?
Yes, in most states. Requirements vary: some states mandate checking the PMP before every controlled substance prescription, others require checking at least once every 3–4 months for ongoing patients. California, New York, Texas, Florida, Pennsylvania, and Illinois all have mandatory PMP check laws. Non-compliance can result in board sanctions.

Can I prescribe buprenorphine (Suboxone) for opioid use disorder via telehealth?
Yes. The federal X-waiver requirement was eliminated in 2022, so any DEA-registered provider can prescribe buprenorphine. Under current DEA waivers, you can initiate buprenorphine treatment via telehealth without an in-person exam (texasnp.org). Some states have additional training or patient limits — check your state’s rules.

If I’m practicing in multiple states via telehealth, do I need separate DEA registrations?
Yes, technically. Federal law requires a separate DEA registration for each state where you maintain a practice or prescribe. However, many telehealth-only providers have gotten by with a single DEA registration in their home state, since they don’t maintain a physical office in other states. This is a gray area — consult a healthcare attorney if you’re prescribing controlled substances across multiple states. The safest approach is to register in each state where you have significant patient volume.

What’s the risk if DEA rules change and I’ve been prescribing controlled substances via telehealth?
If you’ve been prescribing under the current federal waiver in good faith, you’re protected for past actions. New rules will likely be prospective (applying to prescriptions written after the rule change). However, some proposed rules might require you to convert telemedicine-only patients to in-person or hybrid care. The key is to stay informed and adapt your practice when final rules are published. Most experts expect grandfathering or transition periods for existing patients.

Ready to Start Prescribing via Telehealth?

If you’re a psychiatrist or PMHNP looking to expand your practice without the headache of patient acquisition, Klarity Health’s platform handles everything — from matched, pre-qualified patients to built-in telehealth infrastructure and compliance workflows. You control your schedule, set your availability, and only pay when you see patients. No marketing spend, no subscription fees, no gambling on ads.

Explore how Klarity can help you build a thriving telepsychiatry practice while staying fully compliant with state and federal prescribing rules.

Sources and References

The following sources were used to verify prescribing regulations, telehealth policies, scope-of-practice laws, and reimbursement data referenced in this article:

1. Texas Nurse Practitioners Association – DEA Telemedicine Extension Announcement (Oct 6, 2023)
   texasnp.org
   Primary source on federal DEA controlled substance teleprescribing waiver extended through December 31, 2025.

2. National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates’ (Aug 15, 2025)
   natlawreview.com
   Analysis of evolving federal and state telehealth controlled substance rules, including DEA proposals and state-level parity laws.

3. California Board of Registered Nursing – AB 890 Implementation FAQs (Updated Nov 2023)
   www.rn.ca.gov
   Official guidance on California’s 103 NP and 104 NP certifications (transition to full practice authority for experienced NPs by 2026).

4. Texas Board of Nursing – APRN Practice FAQ (Revised 2021)
   www.bon.texas.gov
   Primary source on Texas NP prescriptive authority requirements and physician delegation mandates.

5. Center for Connected Health Policy – Texas Telehealth Laws (Updated Jan 19, 2026)
   www.cchpca.org
   Comprehensive state-by-state telehealth law database; cited for Texas restrictions on opioid teleprescribing and telemedicine standards.

6. Florida Senate Statutes – Chapter 464 (Nursing) and 456 (Health Professions) (2024)
   www.flsenate.gov
   Primary legal text for Florida NP scope, autonomous practice exclusions for psychiatric NPs, and telehealth controlled substance prescribing carve-out for psychiatric treatment.

7. JDSupra (Rivkin Radler LLP) – ‘New Law Allows Experienced NPs to Practice Without Collaboration’ (April 13, 2022)
   www.jdsupra.com
   Law firm analysis of New York’s 2022 budget amendments permanently allowing NP independence after 3,600 hours of practice.

8. Nixon Peabody Client Alert – ‘New York State Finalizes Telemedicine Rule for Controlled Substances’ (June 18, 2025)
   www.nixonpeabody.com
   Explanation of New York’s final regulations aligning state controlled substance teleprescribing rules with federal DEA waivers.

9. Pennsylvania Coalition of Nurse Practitioners – Scope of Practice Summary (Updated 2022)
   www.pacnp.org
   Professional association overview of Pennsylvania’s collaborative agreement requirements for NPs and Schedule II prescribing limitations.

10. NursePractitionerLicense.com – Illinois NP Practice Limitations (Updated Feb 12, 2024)
    www.nursepractitionerlicense.com
    State-specific licensing guide detailing Illinois’s 4,000-hour collaboration requirement and pathway to Full Practice Authority for NPs.

11. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (2026 rates)
    therathink.com
    Medical billing resource with 2025–26 Medicare reimbursement rates for psychiatric CPT codes (90792, 99213, 99214, etc.).

12. Nurse Practitioner Online – ‘NP Practice Authority Updates 2026’ (Last verified Feb 5, 2026)
    www.nursepractitioneronline.com
    State-by-state analysis of NP scope-of-practice changes, noting ~34 states with full practice authority as of 2025 and recent legislative trends.

13. Zivian Health – ‘2026 NP-Physician Collaboration Regulations Compliance Roadmap’ (Feb 16, 2026)
    zivianhealth.com
    Compliance overview of state-by-state collaborative agreement requirements, chart review mandates, and supervision ratios (e.g., Texas 7-NP-per-physician cap).

14. Texas Legislature Online – SB 406 Analysis (83rd Session, 2013)
    capitol.texas.gov
    Legislative analysis of Texas law capping physician supervision of NPs/PAs and outlining prescriptive authority delegation requirements.

15. Healing Psychiatry Florida – ‘Psychiatrist Shortage by State’ (Jan 15, 2026)
    www.healingpsychiatryflorida.com
    Data-driven analysis of U.S. psychiatrist-to-population ratios and Health Professional Shortage Areas by state, citing official HRSA data.

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship